A 32-gene risk index: a new prognostic approach for prostate cancer progression.
作者信息
Cai Chao, Zhong Wei-De, McDougal W Scott, Wu Chin-Lee
机构信息
Department of Urology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
出版信息
Asian J Androl. 2013 Sep;15(5):590-1. doi: 10.1038/aja.2013.85. Epub 2013 Jun 10.
Abstract
摘要
相似文献
1
A 32-gene risk index: a new prognostic approach for prostate cancer progression.一种32基因风险指数：前列腺癌进展的新预后评估方法。
Asian J Androl. 2013 Sep;15(5):590-1. doi: 10.1038/aja.2013.85. Epub 2013 Jun 10.
2
Development and validation of a 32-gene prognostic index for prostate cancer progression.开发并验证了一个用于前列腺癌进展的 32 基因预后指数。
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6121-6. doi: 10.1073/pnas.1215870110. Epub 2013 Mar 26.
3
Epidemiology, diagnosis and treatment of prostate cancer.前列腺癌的流行病学、诊断与治疗
Radiol Technol. 1996 Sep-Oct;68(1):39-64; quiz 65-8.
4
Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.改善原发性前列腺癌诊断时的临床风险分层：一项预后建模研究。
PLoS Med. 2016 Aug 2;13(8):e1002063. doi: 10.1371/journal.pmed.1002063. eCollection 2016 Aug.
5
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.剑桥预后分组可改善原发性非转移性前列腺癌诊断时疾病死亡率的预测：验证性研究。
BMC Med. 2018 Feb 28;16(1):31. doi: 10.1186/s12916-018-1019-5.
6
New prognostic model for prostate cancer.前列腺癌的新预后模型
Lancet Oncol. 2019 Apr;20(4):e198. doi: 10.1016/S1470-2045(19)30185-8. Epub 2019 Mar 22.
7
TMPRSS2:ERG gene fusion a new genetic marker for prostate cancer progression.TMPRSS2:ERG基因融合是前列腺癌进展的一种新的遗传标志物。
Cancer Biol Ther. 2007 Jan;6(1):46-7. doi: 10.4161/cbt.6.1.3738.
8
Prognostic factors and clinical significance of cancers detected by screening: growth rate and progression of prostate cancer.筛查发现的癌症的预后因素及临床意义：前列腺癌的生长速率与进展
J Urol. 1994 Nov;152(5 Pt 2):1707-8. doi: 10.1016/s0022-5347(17)32367-4.
9
Transrectal ultrasonography in the followup of prostatic carcinoma patients: a new prognostic parameter?
J Urol. 1984 May;131(5):903-5. doi: 10.1016/s0022-5347(17)50705-3.
10
Diagnostic and prognostic value of molecular cytogenetic analyses of sextant biopsies from prostate cancer suspects.对疑似前列腺癌患者六分区活检组织进行分子细胞遗传学分析的诊断及预后价值
Crit Rev Oncog. 2006 Dec;12(3-4):303-4; discussion 304. doi: 10.1615/critrevoncog.v12.i3-4.100.
本文引用的文献
1
Development and validation of a 32-gene prognostic index for prostate cancer progression.开发并验证了一个用于前列腺癌进展的 32 基因预后指数。
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6121-6. doi: 10.1073/pnas.1215870110. Epub 2013 Mar 26.
2
Cancer statistics, 2013.癌症统计数据，2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).根治性前列腺切除术后高危前列腺癌的术后放疗：一项随机对照试验（EORTC 试验 22911）的长期结果。
Lancet. 2012 Dec 8;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. Epub 2012 Oct 19.
4
Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension.患有器官局限性前列腺癌且切缘阳性的男性发生生化失败的风险与患有包膜外侵犯的男性相似。
Urology. 2011 Jul;78(1):121-5. doi: 10.1016/j.urology.2010.10.036. Epub 2011 Mar 16.
5
Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR.通过实时逆转录聚合酶链反应对临床局限性前列腺癌患者盆腔淋巴结微转移进行定量检测。
Clin Cancer Res. 2007 Feb 15;13(4):1192-7. doi: 10.1158/1078-0432.CCR-05-2706.
6
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.前列腺癌根治术后生化复发的定义：标准化定义提案
J Clin Oncol. 2006 Aug 20;24(24):3973-8. doi: 10.1200/JCO.2005.04.0756.
7
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.耻骨后根治性前列腺切除术术后的长期无生化疾病生存及癌症特异性生存。约翰霍普金斯医院15年的经验。
Urol Clin North Am. 2001 Aug;28(3):555-65. doi: 10.1016/s0094-0143(05)70163-4.
8
The clinical usefulness of prostate specific antigen: update 1994.前列腺特异性抗原的临床应用：1994年更新
J Urol. 1994 Nov;152(5 Pt 1):1358-68. doi: 10.1016/s0022-5347(17)32422-9.
Zotero 插件